erratum|hybrid
·인용수 0
·2025
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
Won Seog Kim, Tae Min Kim, Seok‐Goo Cho, Isidro Jarque, Elżbieta Iskierka‐Jazdzewska, Li Mei Poon, H. Miles Prince, Huilai Zhang, Junning Cao, Mingzhi Zhang, Benoît Tessoulin, Sung Yong Oh, Francesca Lim, Cecilia Carpio, Tran‐Der Tan, Sabarish Ayyappan, Antonio Gutiérrez, Jingxian Cai, Melanie Ufkin, Saleem Shariff, Jurriaan Brouwer‐Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Jan Walewski, on behalf of the ELM-2 Investigators, Hannah Rose, Geoffrey Chong, Vinod Ganju, Michael Chu, Mary-Margaret Keating, Yuqin Song, Jun Zhu, Xiaoyan Ke, Shuhua Yi, Huilai Zhang, Qingyuan Zhang, Liqun Zou, Mingzhi Zhang, Dengju Li, Wenbin Qian, Ou Bai, Li Gao, Jie Jin, Caixia Li, Huiqiang Huang, Zheng Wei, Youhua Chen, Pengcheng He, Gandhi Laurent Damaj, Kamal Bouabdballah, Emmanuel Bachy, Corinne Haioun, Franck Morschhauser, Sylvain Choquet, Vincent Delwail, Catherine Thieblemont, Johannes Duell, Thomas Weber, Paul Graf La Rosee, Holger Hebart, Enrico Capochiani, Vittorio Zilioli, Francesca Rossi, Stefano Luminari, Pier Luigi Zinzani, Laura Bagnato, Gianluca Gaidano, Marco Brociner, Cristina Skert, Monica Tani, Roberta Battistini, Leonardo Flenghi, Ryusuke Yamamoto, Kunihiro Tsukasaki, Kenichi Ishizawa, Tomomi Tobai, Toshiki Uchida, Yosuke Minami, Nobuhiko Yamauchi, Junichiro Yuda, Masahiro Takeuchi, Hirokazu Nagai, Youko Suehiro, Yoshiaki Ogawa, Junya Kuroda, Tatsuro Jo, Hirohisa Nakamae, Isao Yoshida, Michal Taszner, Ewa Lech-Maranda, Wanda Knopinska-Posluszny, Tomasz Wrobel, Tadeusz Robak, Wen Son Hsieh, Shin Yeu Ong, Hyeon-Seok Eom, Yeung-Chul Mun, Young Rok Do, Jin Seok Kim
Nature Cancer